Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of ...

Additional early research suggested that combining metformin and clemastine may promote remyelination, offering hope for ...

With over 1 million Americans affected by multiple sclerosis (MS), we wanted to learn more about its symptoms, particularly ...

Most people with relapsing MS who were treated with Briumvi for six years did not have confirmed disability progression, a ...

Treatment with Sanofi's frexalimab was seen in a study to safely maintain disease control over 2.5 years in adults with relapsing forms of MS.

Selma Blair reveals her multiple sclerosis went undiagnosed for decades despite experiencing symptoms since childhood, with ...

A man with multiple sclerosis (MS) has been awarded a Guinness World Record - and now has his sights set on the next ...

Selma Blair’s lifelong health struggles were signs of multiple sclerosis that doctors wouldn't acknowledge until she was in ...

Ten months after having a baby, I received a devastating diagnosis – and it’s more common than you might think.

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...

Selma Blair has bravely opened up about how her multiple sclerosis (MS) was dismissed for decades despite a very obvious ...

Basel, September 24, 2025 – Novartis today announced new data from two Kesimpta ® (ofatumumab) studies in relapsing multiple sclerosis (RMS) that will be presented at the European Committee for ...